keyword
MENU ▼
Read by QxMD icon Read
search

smfm

keyword
https://www.readbyqxmd.com/read/28514843/single-cell-real-time-visualization-and-quantification-of-perylene-bioaccumulation-in-microorganisms
#1
Xin Jin, Xuejun Guo, Deshu Xu, Yanna Zhao, Xinghui Xia, Fan Bai
Bioaccumulation of perylene in Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) was visualized and quantified in real time with high sensitivity at high temporal resolution. For the first time, single-molecule fluorescence microscopy (SMFM) with a microfluidic flow chamber and temperature control has enabled us to record the dynamic process of perylene bioaccumulation in single bacterial cells and examine the cell-to-cell heterogeneity. Although with identical genomes, individual E. coli cells exhibited a high degree of heterogeneity in perylene accumulation dynamics, as shown by the high coefficient of variation (C...
May 17, 2017: Environmental Science & Technology
https://www.readbyqxmd.com/read/28412084/coding-update-of-the-smfm-definition-of-low%C3%A2-risk%C3%A2-for-cesarean-delivery-from-icd-9-cm-to%C3%A2-icd-10-cm
#2
Joanne Armstrong, Patricia McDermott, George R Saade, Sindhu K Srinivas
In 2015, the Society for Maternal-Fetal Medicine developed a low risk for cesarean delivery definition based on administrative claims-based diagnosis codes described by the International Classification of Diseases, Ninth Revision, Clinical Modification. The Society for Maternal-Fetal Medicine definition is a clinical enrichment of 2 available measures from the Joint Commission and the Agency for Healthcare Research and Quality measures. The Society for Maternal-Fetal Medicine measure excludes diagnosis codes that represent clinically relevant risk factors that are absolute or relative contraindications to vaginal birth while retaining diagnosis codes such as labor disorders that are discretionary risk factors for cesarean delivery...
April 13, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28342521/endovascular-management-of-chronic-symptomatic-aortic-dissection-with-the-streamliner-multilayer-flow-modulator-twelve-month-outcomes-from-the-global-registry
#3
MULTICENTER STUDY
Sherif Sultan, Edel P Kavanagh, Florian Stefanov, Mohamed Sultan, Ala Elhelali, Victor Costache, Edward Diethrich, Niamh Hynes
OBJECTIVE: Reported are initial 12-month outcomes of patients with chronic symptomatic aortic dissection managed by the Streamliner Multilayer Flow Modulator (SMFM; Cardiatis, Isnes, Belgium). Primary end points were freedom from rupture- and aortic-related death, and reduction in false lumen index. Secondary end points were patency of great vessels and visceral branches, and freedom of stroke, paraplegia, and renal failure. METHODS: Out of 876 SMFM implanted globally, we have knowledge of 542...
April 2017: Journal of Vascular Surgery
https://www.readbyqxmd.com/read/28198038/likelihood-of-cesarean-delivery-after-applying-leading-active-labor-diagnostic-guidelines
#4
Jeremy L Neal, Nancy K Lowe, Julia C Phillippi, Sharon L Ryan, Amy M Knupp, Mary S Dietrich, Stephen F Thung
BACKGROUND: Friedman, the United Kingdom's National Institute for Health and Care Excellence (NICE), and the American College of Obstetricians and Gynecologists/Society for Maternal-Fetal Medicine (ACOG/SMFM) support different active labor diagnostic guidelines. Our aims were to compare likelihoods for cesarean delivery among women admitted before vs in active labor by diagnostic guideline (within-guideline comparisons) and between women admitted in active labor per one or more of the guidelines (between-guideline comparisons)...
February 15, 2017: Birth
https://www.readbyqxmd.com/read/28142152/improving-safe-and-effective-use-of-drugs-in-pregnancy-and-lactation-workshop-summary
#5
Laura E Riley, Alison G Cahill, Richard Beigi, Renate Savich, George Saade
In February 2015, given high rates of use of medications by pregnant women and the relative lack of data on safety and efficacy of many drugs utilized in pregnancy, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Society for Maternal-Fetal Medicine (SMFM), the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) convened a group of experts to review the "current" state of the clinical care and science regarding medication use during the perinatal period...
January 31, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28135740/smfm-2017-meeting-highlights-saturday-podcast
#6
(no author information available yet)
No abstract text is available yet for this article.
January 30, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28131106/smfm-2017-meeting-highlights-friday-podcast
#7
(no author information available yet)
No abstract text is available yet for this article.
January 28, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28129660/smfm-2017-meeting-highlights-thursday-podcast
#8
(no author information available yet)
No abstract text is available yet for this article.
January 27, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28126367/the-choice-of-progestogen-for-the-prevention-of%C3%A2-preterm-birth-in-women-with-singleton-pregnancy-and-prior-preterm-birth
#9
(no author information available yet)
No abstract text is available yet for this article.
January 23, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28126365/prenatal-acetaminophen-use%C3%A2-and-outcomes%C3%A2-in%C3%A2-children
#10
(no author information available yet)
No abstract text is available yet for this article.
March 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28108157/the-role-of-cervical-pessary-placement-to-prevent-preterm-birth-in-clinical%C3%A2-practice
#11
(no author information available yet)
No abstract text is available yet for this article.
January 18, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28108156/the-role-of-ultrasound-in-women-who-undergo-cell-free-dna-screening
#12
Mary E Norton, Joseph R Biggio, Jeffrey A Kuller, Sean C Blackwell
The introduction of cell-free DNA screening for aneuploidy into obstetric practice in 2011 revolutionized the strategies utilized for prenatal testing. The purpose of this document is to review the current data on the role of ultrasound in women who have undergone or are considering cell-free DNA screening. The following are Society for Maternal-Fetal Medicine recommendations: (1) in women who have already received a negative cell-free DNA screening screen, ultrasound at 11-14 weeks of gestation solely for the purpose of nuchal translucency measurement (Current Procedural Terminology code 76813) is not recommended (grade 1B); (2) we recommend that diagnostic testing should not be recommended to patients solely for the indication of an isolated soft marker in the setting of a negative cell-free DNA screen (grade 2B); (3) in women with an isolated soft marker without other clinical implications (ie, choroid plexus cyst or echogenic intracardiac focus) and a negative cell-free DNA screen, we recommend describing the finding as not clinically significant or as a normal variant (grade 2B); (4) in women with an isolated soft marker that has no other clinical implication (ie, choroid plexus cyst or echogenic intracardiac focus) and a negative first- or second-trimester screening result, we recommend describing the finding as not clinically significant or as a normal variant (grade 2B); (5) we recommend that all women in whom a structural abnormality is identified by ultrasound should be offered diagnostic testing with chromosomal microarray (grade 1A); and (6) we recommend against routine screening for microdeletions with cell-free DNA screening (grade 1B)...
March 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28061523/smfm-2017-pregnancy-meeting-looking-ahead-to-the-scientific-program-podcast
#13
(no author information available yet)
No abstract text is available yet for this article.
January 6, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/27889286/computational-fluid-analysis-of-symptomatic-chronic-type-b-aortic-dissections-managed-with-the-streamliner-multilayer-flow-modulator
#14
Florian Stefanov, Sherif Sultan, Liam Morris, Ala Elhelali, Edel P Kavanagh, Violet Lundon, Mohamed Sultan, Niamh Hynes
OBJECTIVE: Managing symptomatic chronic type B aortic dissection (SCTBAD) by the Streamliner Multilayer Flow Modulator (SMFM) stent (Cardiatis, Isnes, Belgium) is akin to provisional structural support to induce complete attachment of the dissection flap, but with the ability of aortic remolding. This study investigated the SMFM's capability to enact healing of SCTBAD. METHODS: Clinical data for 12 cases comprising preoperative and postoperative treatment of SCTBAD were obtained from a multicenter database hosted by the Multilayer Flow Modulator Global Registry, Ireland...
April 2017: Journal of Vascular Surgery
https://www.readbyqxmd.com/read/27819164/current-trends-in-the-diagnosis-and-management-of-gestational-diabetes-mellitus-in-the-united-states
#15
Brianne E Bimson, Barak M Rosenn, Sara A Morris, Elizabeth B Sasso, Rachelle A Schwartz, Lois E Brustman
OBJECTIVE: To assess current practice patterns among members of the Society for Maternal-Fetal Medicine (SMFM) with respect to the diagnosis and management of gestational diabetes mellitus (GDM). METHODS: A 38 question survey on GDM diagnosis and management was distributed to SMFM members. RESULTS: 2330 SMFM members were surveyed with a 40% response rate. Overall, 90.6% of respondents recommend a 2-step (versus a 1-step) diagnostic test. Cutoff values for the 1-h-50 g glucose challenge test vary from 130-140 mg/dL, but the majority (83%) adopts Carpenter Coustan criteria for the 3-h-100 g oral glucose tolerance test...
November 24, 2016: Journal of Maternal-fetal & Neonatal Medicine
https://www.readbyqxmd.com/read/27794277/smfm-2016-archive-hypertension-part-6-podcast
#16
(no author information available yet)
No abstract text is available yet for this article.
October 29, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27793058/smfm-2016-archive-hypertension-part-5-podcast
#17
(no author information available yet)
No abstract text is available yet for this article.
October 28, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27788535/smfm-2016-archive-hypertension-part-4-podcast
#18
(no author information available yet)
No abstract text is available yet for this article.
October 27, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27784119/smfm-2016-archive-hypertension-part-3-podcast
#19
(no author information available yet)
No abstract text is available yet for this article.
October 26, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27780276/smfm-2016-archive-hypertension-part-2-podcast
#20
(no author information available yet)
No abstract text is available yet for this article.
October 25, 2016: American Journal of Perinatology
keyword
keyword
64853
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"